Proposed Data Collections Submitted for Public Comment and Recommendations, 45427-45428 [E7-15894]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 156 / Tuesday, August 14, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the President’s
Council on Bioethics on September 6–
7, 2007
mstockstill on PROD1PC66 with NOTICES
AGENCY: The President’s Council on
Bioethics, HHS.
ACTION: Notice.
SUMMARY: The President’s Council on
Bioethics (Edmund D. Pellegrino, MD,
Chairman) will hold its thirtieth
meeting, at which it will (1) Discuss a
projected ‘‘white paper’’ on the
neurological standard for the
determination of death; (2) continue the
exploratory phase of a potential inquiry
into the ‘‘crisis’’ of the healing
professions with expert presentations
and Council discussions; and (3)
continue the exploratory phase of a
potential inquiry into ethical issues
associated with nanotechnology with
expert presentations and Council
discussions. Subjects discussed at past
Council meetings (although not on the
agenda for the September 2007 meeting)
include: therapeutic and reproductive
cloning, assisted reproduction,
reproductive genetics, the ethics of
health care, neuroscience, aging
retardation, organ transplantation,
newborn screening, human dignity,
personalized medicine, and lifespanextension. Publications issued by the
Council to date include: Human Cloning
and Human Dignity: An Ethical Inquiry
(July 2002); Beyond Therapy:
Biotechnolody and the Pursuit of
Happiness (October 2003); Being
Human: Readings from the President’s
Council on Bioethics (December 2003);
Monitoring Stem Cell Research (January
2004), Reproduction and Responsibility:
The Regulation of New Biotechnologies
(March 2004), Alternative Sources of
Human Pluripotent Stem Cells: A White
Paper (May 2005), and Taking Care:
Ethical Caregiving in Our Aging Society
(September 2005). Reports on the
bioethical significance of the concept of
human dignity and on organ
procurement, transplantation, and
allocation are forthcoming.
DATES: The meeting will take place
Thursday, September 6, 2007, from 9 am
to 5:15 pm, ET; and Friday, September
7, 2007, from 8:30 am to 11:45 am, ET.
ADDRESSES: The Carolina Inn, 211
Pittsboro Street, Chapel Hill, NC 27516.
Phone 919–933–2001 or 1–800–962–
8519.
Agenda: The meeting agenda will be
posted at https://www.bioethics.gov.
Public Comments: The Council
encourages public input, either in
person or in writing. At this meeting,
VerDate Aug<31>2005
16:35 Aug 13, 2007
Jkt 211001
interested members of the public may
address the Council, beginning at 11:30
am, on Friday, September 7. Comments
are limited to no more than five minutes
per speaker or organization. As a
courtesy, please inform Ms. Diane M.
Gianelli, Director of Communications,
in advance of your intention to make a
public statement, and give your name
and affiliation. To submit a written
statement, mail or e-mail it to Ms.
Gianelli at one of the addresses given
below.
FOR FURTHER INFORMATION CONTACT: Ms.
Diane M. Gianelli, Director of
Communications, The President’s
Council on Bioethics, 1425 New York
Avenue, NW., Suite C100 Washington,
DC 20005. Telephone 202/296–4669. Email info@bioethics.gov. Web site:
https://www.bioethics.gov.
Dated: August 6, 2007.
F. Daniel Davis,
Executive Director, The President’s Council
on Bioethics.
[FR Doc. 07–3948 Filed 8–13–07; 8:45 am]
BILLING CODE 4154–07–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Misconduct in Science
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given that
the Office of Research Integrity (ORI),
the Assistant Secretary for Health, and
another Federal agency have taken final
action in the following case:
Juan Carlos Jorge-Rivera, Ph.D.,
Dartmouth College: Based on the
findings of an inquiry conducted by
Dartmouth College, an investigation
conducted by another Federal agency,
and additional analysis conducted by
the Office of Research Integrity (ORI)
during its oversight review, the U.S.
Public Health Service (PHS) found that
Juan Carlos Jorge-Rivera, Ph.D., former
postdoctoral fellow, Department of
Physiology, Dartmouth College, engaged
in misconduct in science in research
funded by National Institute of
Neurological Disorders and Stroke
(NINDS), National Institutes of Health
(NIH), grant R01 NS28668.
Specifically, Dr. Jorge-Rivera
knowingly and intentionally falsified
amplifier gain in at least eleven (11)
experiments of his postdoctoral research
aimed at measuring the effects of
anabolic steroids on GABAnergic
current in brain cells and reported the
falsified data in Figures 4 and 6 of the
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
45427
following paper: Jorge-Rivera, J.C.,
McIntyre, K.L., & Henderson, L.P.
‘‘Anabolic steroids induce region- and
subunit-specific modulations of GABA
receptor mediated currents in the rat
forebrain.’’ Journal of Neurophysiology
83:3299–3309, 2000.
Dr. Jorge-Rivera has been debarred by
the Federal agency with joint
jurisdiction for a period of two (2) years,
beginning on January 11, 2007, and
ending on January 11, 2009.
ORI has implemented the following
administrative actions:
(1) For a period of three (3) years,
beginning on June 23, 2007, and ending
on June 22, 2010, Dr. Jorge-Rivera is
prohibited from serving in any advisory
capacity to PHS, including but not
limited to service on any PHS advisory
committee, board, and/or peer review
committee, or as a consultant; and
(2) for a period of three (3) years,
beginning at the end of his debarment
period (January 11, 2009), and ending
on January 10, 2012, Dr. Jorge-Rivera
must submit, in conjunction with each
application for PHS funds, annual
reports, manuscripts, or abstracts of
PHS-funded research in which he is
involved, a certification that the data he
provides are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application or
report.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E7–15881 Filed 8–13–07; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–0677]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
E:\FR\FM\14AUN1.SGM
14AUN1
45428
Federal Register / Vol. 72, No. 156 / Tuesday, August 14, 2007 / Notices
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, Acting
CDC Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
and could affect our ability to monitor
trends in the prevalence of STDs.
The objectives of this proposed data
collection are to: (1) Collect information
about the volume of and type of testing
for chlamydia, gonorrhea, herpes
simplex virus (HSV), syphilis, human
papillomavirus (HPV), bacterial
vaginosis, trichomonas, and pap smears
performed in laboratories in calendar
year 2006 and (2) collect information
about antimicrobial susceptibility
testing for gonorrhea during the
calendar year 2006.
This survey will build on data
collected in 2004 by the Centers for
Disease Control and Prevention on
laboratory test methods and the volume
of testing (Dicker et al. Testing for
Sexually Transmitted Diseases in the
U.S. Public Health Laboratories in 2004.
Sexually Transmitted Diseases. (43):1,
pg. 41–46, Jan. 2007).
CDC anticipates collecting this data
using an on-line survey of 150 public
health laboratories. The survey will take
approximately 25 minutes to complete.
The only cost to respondents is their
time to complete the survey.
Proposed Project
Sexually Transmitted Diseases
Laboratory Methods Survey (OMB No.
0920–0677)—Extension—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Approximately 18.9 million new
cases of sexually transmitted diseases
(STDs) are estimated to occur each year
in the United States. Effective control
and prevention of STDs require prompt
diagnosis which relies on laboratory
testing, proper screening of those at risk,
and effective treatment. Thus, an
understanding of the current laboratory
testing practices for STDs in the U.S. is
critical, not only to monitor capacity but
to assess current practices of public
health and private laboratories to
appropriately test for these diseases.
Additionally, these testing practices
could affect the resources available to
public health departments for STD
screening and surveillance programs
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Types of data collection
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Public Health Laboratories ..............................................................................
150
1
25/60
63
Total ..........................................................................................................
........................
........................
........................
63
Dated: August 8, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–15894 Filed 8–13–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–0707]
mstockstill on PROD1PC66 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
VerDate Aug<31>2005
16:35 Aug 13, 2007
Jkt 211001
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4604 or send
comments to Maryam Daneshvar, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
Proposed Project
2005 Lead Disclosure Rule Public
Awareness Survey—Extension—
National Center for Environmental
Health (NCEH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The proposed 2005 Lead Disclosure
Rule Public Awareness Survey assesses
small and medium-sized rental property
owners’ self-reported awareness of and
compliance with the Lead Disclosure
Rule. The Lead Disclosure Rule requires
property owners to disclose to
prospective tenants and buyers the
presence of lead paint and lead-based
paint hazards in residential properties
built before 1978, if known by the
owners. The rule was published under
the authority of Title X of the Housing
and Community Development Act of
1992 by the Department of Housing and
Urban Development (HUD) at 24 CFR
part 35, subpart A, and by the
Environmental Protection Agency (EPA)
at 40 CFR 745, subpart F.
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 72, Number 156 (Tuesday, August 14, 2007)]
[Notices]
[Pages 45427-45428]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15894]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-07-0677]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the
[[Page 45428]]
proposed projects or to obtain a copy of the data collection plans and
instruments, call 404-639-5960 or send comments to Maryam Daneshvar,
Acting CDC Reports Clearance Officer, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Sexually Transmitted Diseases Laboratory Methods Survey (OMB No.
0920-0677)--Extension--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Approximately 18.9 million new cases of sexually transmitted
diseases (STDs) are estimated to occur each year in the United States.
Effective control and prevention of STDs require prompt diagnosis which
relies on laboratory testing, proper screening of those at risk, and
effective treatment. Thus, an understanding of the current laboratory
testing practices for STDs in the U.S. is critical, not only to monitor
capacity but to assess current practices of public health and private
laboratories to appropriately test for these diseases. Additionally,
these testing practices could affect the resources available to public
health departments for STD screening and surveillance programs and
could affect our ability to monitor trends in the prevalence of STDs.
The objectives of this proposed data collection are to: (1) Collect
information about the volume of and type of testing for chlamydia,
gonorrhea, herpes simplex virus (HSV), syphilis, human papillomavirus
(HPV), bacterial vaginosis, trichomonas, and pap smears performed in
laboratories in calendar year 2006 and (2) collect information about
antimicrobial susceptibility testing for gonorrhea during the calendar
year 2006.
This survey will build on data collected in 2004 by the Centers for
Disease Control and Prevention on laboratory test methods and the
volume of testing (Dicker et al. Testing for Sexually Transmitted
Diseases in the U.S. Public Health Laboratories in 2004. Sexually
Transmitted Diseases. (43):1, pg. 41-46, Jan. 2007).
CDC anticipates collecting this data using an on-line survey of 150
public health laboratories. The survey will take approximately 25
minutes to complete. The only cost to respondents is their time to
complete the survey.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Types of data collection respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Public Health Laboratories...................... 150 1 25/60 63
---------------------------------------------------------------
Total....................................... .............. .............. .............. 63
----------------------------------------------------------------------------------------------------------------
Dated: August 8, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-15894 Filed 8-13-07; 8:45 am]
BILLING CODE 4163-18-P
